Simultaneous substrate and ubiquitin modification recognition by bispecific antibodies allows detection of ubiquitinated RIP1 and RIP2
Ontology highlight
ABSTRACT: Ubiquitination is crucial for the dynamic regulation of diverse signaling pathways. To
enhance understanding of ubiquitination mediated signaling, we generated a new class
of bispecific antibodies which combine recognition of ubiquitination substrates and
specific polyubiquitin linkages. RIP1-K63 or RIP1-linear (Lin) linkage polyubiquitin
bispecific antibodies can detect linkage-specific RIP1 ubiquitination in cells and in
tissues, and also reveal RIP1 ubiquitination by immunofluorescence. In a similar
fashion, RIP2 ubiquitination with K63 or linear linkages can be specifically detected with
RIP2-K63 and RIP2-Lin bispecific antibodies. Furthermore, using RIP2-K63 and RIP2-
Lin bispecific antibodies we examined IBD patient samples and found prominent K63-
linked and linear RIP2 ubiquitination in ulcerative colitis and Crohn's disease patient
samples. We also developed a bispecific antibody (K63-Lin) that can simultaneously
recognize K63-linked and linear ubiquitination in a variety of signaling pathways.
Collectively, these bispecific antibodies provide a novel conceptual paradigm for
potential future development of inflammatory markers.
INSTRUMENT(S): Orbitrap Fusion Lumos
ORGANISM(S): Homo Sapiens (ncbitaxon:9606)
SUBMITTER: Domagoj Vucic
PROVIDER: MSV000091134 | MassIVE | Tue Jan 24 14:48:00 GMT 2023
REPOSITORIES: MassIVE
ACCESS DATA